Sustained translational repression by eIF2α-P mediates prion neurodegeneration

Area of Science:

• Neuroscience
• Molecular Biology
• Cellular Biology

Background:

• Neurodegenerative diseases like Alzheimer's, Parkinson's, and prion diseases involve misfolded protein accumulation.
• The unfolded protein response (UPR) is a cellular defense against misfolded proteins, including shutting down protein translation via eIF2α-P.
• The link between UPR activation, eIF2α-P, and neurodegeneration remains unclear.

Purpose of the Study:

• To investigate the role of prion protein accumulation and eIF2α-P in prion-induced neurodegeneration.
• To determine if restoring protein translation can be neuroprotective in prion disease models.
• To explore therapeutic strategies targeting translational control for neurodegenerative disorders.

Main Methods:

• Utilized prion-diseased mouse models to study prion protein accumulation and its effects on protein synthesis.
• Investigated the impact of eIF2α-P levels on synaptic function and neuronal loss.
• Employed genetic (GADD34 overexpression, RNA interference) and pharmacological (salubrinal) approaches to modulate eIF2α-P and protein translation.

Main Results:

• Prion protein accumulation led to sustained translational repression via eIF2α-P, causing synaptic failure and neuronal loss in mice.
• Overexpressing GADD34 or reducing prion protein levels decreased eIF2α-P, restored protein translation, and rescued synaptic deficits and neuronal loss, increasing survival.
• Inhibition of eIF2α-P dephosphorylation with salubrinal worsened neurotoxicity and reduced survival.

Conclusions:

• Persistent translational repression mediated by eIF2α-P is a key mechanism of neurodegeneration in prion disease.
• Restoring protein translation rates offers a neuroprotective strategy.
• Targeting common pathways like translational control, rather than disease-specific mechanisms, holds promise for treating diverse neurodegenerative diseases.